淋巴细胞-C反应蛋白比值作为预测结直肠癌手术与肿瘤结局的新标志物
该研究纳入477例结直肠癌患者,评估术前九种炎症标志物组合对复发的预测价值,发现淋巴细胞-C反应蛋白比值(LCR)与复发相关性最高。术前LCR降低(最佳截断值6000)是总生存和无病生存的独立预后因素,也是术后并发症和手术部位感染的独立危险因素,并在验证队列中确认。
要点
- 术前LCR降低与结直肠癌不良病理特征及晚期分期显著相关。
- LCR截断值6000可独立预测无病生存和总生存。
- 术前LCR降低是术后并发症和手术部位感染的独立危险因素。
核心结论
- 术前LCR是结直肠癌患者围手术期和术后管理的有用标志物。
研究设计与样本
- 研究纳入477例结直肠癌患者,分为发现队列和验证队列,评估术前九种炎症标志物组合对复发的预测价值。
主要发现
- 在结直肠癌患者中,淋巴细胞计数联合C反应蛋白水平与其他参数相比,与复发的相关性最高。
- 术前LCR降低与低分化组织学、晚期T分期、淋巴结转移、远处转移和晚期分期分类显著相关。
- 术前LCR降低(最佳截断值6000)是无病生存和总生存的独立预后因素,也是术后并发症和手术部位感染的独立危险因素。
- 在独立验证队列中确认,术前LCR降低是无病生存和总生存的独立预后因素,也是术后并发症和手术部位感染的独立预测因素。
关键数值与推荐
- 术前LCR降低的最佳截断值为6000。
- 术前LCR降低与低分化组织学、晚期T分期、淋巴结转移、远处转移和晚期分期分类显著相关。
- 术前LCR降低是无病生存和总生存的独立预后因素。
- 术前LCR降低是术后并发症和手术部位感染的独立危险因素。
临床怎么用
- 术前检测LCR有助于识别结直肠癌患者中预后较差及术后并发症和手术部位感染风险较高的个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systemic inflammation via host-tumor interactions is currently recognized as a hallmark of cancer. The aim of this study was to evaluate the prognostic value of various combinations of inflammatory factors using preoperative blood, and to assess the clinical significance of our newly developed inflammatory score in colorectal cancer (CRC) patients. METHOD: In total 477 CRC patients from the discovery and validation cohorts were enrolled in this study. We assessed the predictive impact for recurrence using a combination of nine inflammatory markers in the discovery set, and focused on lymphocyte-C-reactive protein ratio (LCR) to elucidate its prognostic and predictive value for peri-operative risk in both cohorts. RESULTS: A combination of lymphocytic count along with C-reactive protein levels demonstrated the highest correlation with recurrence compared with other parameters in CRC patients. Lower levels of preoperative LCR significantly correlated with undifferentiated histology, advanced T stage, presence of lymph node metastasis, distant metastasis, and advanced stage classification. Decreased preoperative LCR (using an optimal cut-off threshold of 6000) was an independent prognostic factor for both disease-free survival and overall survival, and emerged as an independent risk factor for postoperative complications and surgical-site infections in CRC patients. Finally, we assessed the clinical feasibility of LCR in an independent validation cohort, and confirmed that decreased preoperative LCR was an independent prognostic factor for both disease-free survival and overall survival, and was an independent predictor for postoperative complications and surgical-site infections in CRC patients. CONCLUSION: Preoperative LCR is a useful marker for perioperative and postoperative management of CRC patients.
引用
- Okugawa Y, Toiyama Y, Yamamoto A, et al. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer. Ann Surg. 2020. PMID: 32675548. doi:10.1097/SLA.0000000000003239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。